{"entity":"intuitive-surgical","id":"ent_intuitive-surgical","name":"Intuitive Surgical","from":"2025-11-09","to":"2026-11-09","page":"https://asof.is/record/intuitive-surgical/diff?from=2025-11-09&to=2026-11-09","summary":"Between 2025-11-09 and 2026-11-09, Intuitive Surgical's record changed in 20 facts: 4 replaced (net income $2.32 billion → $2.86 billion; operating income $2.35 billion → $2.95 billion; research and development $1.15 billion → $1.31 billion and 1 more), 8 added, 8 ended; 11 unchanged.","counts":{"changed":20,"added":8,"ended":8,"replaced":4,"unchanged":11,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"cash_and_equivalents","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_net_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_operating_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_research_and_development","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_revenue","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"shares_outstanding","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_assets","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_equity","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"operating_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"research_and_development","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"revenue","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"ceo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cfo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"chair","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"state_of_incorporation","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[{"id":"clm_B0395B58B4AF","predicate":"cash_and_equivalents","value":"2,978,100,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical cash and equivalents: 2,978,100,000 United States dollar\", as of 2026-09-30. Claim clm_B0395B58B4AF, https://asof.is/claim/clm_B0395B58B4AF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_B0395B58B4AF","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_AA7B0BF5D764","predicate":"quarterly_net_income","value":"522,800,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly net income: 522,800,000 United States dollar\", as of 2026-09-30. Claim clm_AA7B0BF5D764, https://asof.is/claim/clm_AA7B0BF5D764, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_AA7B0BF5D764","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_BDF3583AB18F","predicate":"quarterly_operating_income","value":"592,600,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly operating income: 592,600,000 United States dollar\", as of 2026-09-30. Claim clm_BDF3583AB18F, https://asof.is/claim/clm_BDF3583AB18F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_BDF3583AB18F","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_92C490313BF8","predicate":"quarterly_research_and_development","value":"408,300,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly research and development: 408,300,000 United States dollar\", as of 2026-09-30. Claim clm_92C490313BF8, https://asof.is/claim/clm_92C490313BF8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_92C490313BF8","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_E2C4559E07EF","predicate":"quarterly_revenue","value":"3,048,700,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly revenue: 3,048,700,000 United States dollar\", as of 2026-09-30. Claim clm_E2C4559E07EF, https://asof.is/claim/clm_E2C4559E07EF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_E2C4559E07EF","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_E68405B65E72","predicate":"shares_outstanding","value":"346,643,718 shares","valid_from":"2026-10-15","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical shares outstanding: 346,643,718 shares\", as of 2026-10-15. Claim clm_E68405B65E72, https://asof.is/claim/clm_E68405B65E72, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_E68405B65E72","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_002A77C5CE1B","predicate":"total_assets","value":"19,349,100,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical total assets: 19,349,100,000 United States dollar\", as of 2026-09-30. Claim clm_002A77C5CE1B, https://asof.is/claim/clm_002A77C5CE1B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_002A77C5CE1B","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_49D2BFCFD295","predicate":"total_equity","value":"15,986,200,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical total equity: 15,986,200,000 United States dollar\", as of 2026-09-30. Claim clm_49D2BFCFD295, https://asof.is/claim/clm_49D2BFCFD295, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm.","url":"https://asof.is/claim/clm_49D2BFCFD295","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000071/0001035267-26-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-10-21"}}],"ended":[{"id":"clm_C8C5679E8998","predicate":"cash_and_equivalents","value":"2,806,600,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical cash and equivalents: 2,806,600,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_C8C5679E8998, https://asof.is/claim/clm_C8C5679E8998, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_C8C5679E8998","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_162C7DD4E5E7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_2210EF769577","predicate":"quarterly_net_income","value":"704,400,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly net income: 704,400,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_2210EF769577, https://asof.is/claim/clm_2210EF769577, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_2210EF769577","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2729F2D41402","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_F4210E9B4A7F","predicate":"quarterly_operating_income","value":"759,700,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly operating income: 759,700,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_F4210E9B4A7F, https://asof.is/claim/clm_F4210E9B4A7F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_F4210E9B4A7F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2CAA1F578B21","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_DF66EDFAB263","predicate":"quarterly_research_and_development","value":"329,400,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly research and development: 329,400,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_DF66EDFAB263, https://asof.is/claim/clm_DF66EDFAB263, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_DF66EDFAB263","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6BF2BD993B02","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_7178C5B3ECFB","predicate":"quarterly_revenue","value":"2,505,100,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical quarterly revenue: 2,505,100,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_7178C5B3ECFB, https://asof.is/claim/clm_7178C5B3ECFB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_7178C5B3ECFB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_16ECF4983752","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_157E75201A8D","predicate":"shares_outstanding","value":"354,496,073 shares","valid_from":"2025-10-16","valid_to":"2026-01-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical shares outstanding: 354,496,073 shares\", as of 2025-10-16 (until 2026-01-28). Claim clm_157E75201A8D, https://asof.is/claim/clm_157E75201A8D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_157E75201A8D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_81D240849BBD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_3D283A56199E","predicate":"total_assets","value":"19,351,800,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical total assets: 19,351,800,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_3D283A56199E, https://asof.is/claim/clm_3D283A56199E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_3D283A56199E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ED20EC2C2C46","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_853CBAD11448","predicate":"total_equity","value":"16,929,700,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical total equity: 16,929,700,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_853CBAD11448, https://asof.is/claim/clm_853CBAD11448, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm.","url":"https://asof.is/claim/clm_853CBAD11448","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C7E73A8682EC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000209/0001035267-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-22"}}],"replaced":[{"predicate":"net_income","from":{"id":"clm_D037E9567833","predicate":"net_income","value":"2,322,600,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical net income: 2,322,600,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_D037E9567833, https://asof.is/claim/clm_D037E9567833, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm.","url":"https://asof.is/claim/clm_D037E9567833","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4D0E25A0F96D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-01-31"}},"to":{"id":"clm_4D0E25A0F96D","predicate":"net_income","value":"2,856,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical net income: 2,856,000,000 United States dollar\", as of 2025-12-31. Claim clm_4D0E25A0F96D, https://asof.is/claim/clm_4D0E25A0F96D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm.","url":"https://asof.is/claim/clm_4D0E25A0F96D","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-03"}}},{"predicate":"operating_income","from":{"id":"clm_F8FF4087AAFD","predicate":"operating_income","value":"2,348,900,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical operating income: 2,348,900,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_F8FF4087AAFD, https://asof.is/claim/clm_F8FF4087AAFD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm.","url":"https://asof.is/claim/clm_F8FF4087AAFD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2D641B283CF6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-01-31"}},"to":{"id":"clm_2D641B283CF6","predicate":"operating_income","value":"2,945,500,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical operating income: 2,945,500,000 United States dollar\", as of 2025-12-31. Claim clm_2D641B283CF6, https://asof.is/claim/clm_2D641B283CF6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm.","url":"https://asof.is/claim/clm_2D641B283CF6","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2026-02-03"}}},{"predicate":"research_and_development","from":{"id":"clm_058853AB6DD5","predicate":"research_and_development","value":"1,145,300,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical research and development: 1,145,300,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_058853AB6DD5, https://asof.is/claim/clm_058853AB6DD5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm.","url":"https://asof.is/claim/clm_058853AB6DD5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4FD7118879B7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-01-31"}},"to":{"id":"clm_4FD7118879B7","predicate":"research_and_development","value":"1,311,800,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical research and development: 1,311,800,000 United States dollar\", as of 2025-12-31. Claim clm_4FD7118879B7, https://asof.is/claim/clm_4FD7118879B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm.","url":"https://asof.is/claim/clm_4FD7118879B7","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-03"}}},{"predicate":"revenue","from":{"id":"clm_31BDE204C902","predicate":"revenue","value":"8,352,100,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical revenue: 8,352,100,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_31BDE204C902, https://asof.is/claim/clm_31BDE204C902, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm.","url":"https://asof.is/claim/clm_31BDE204C902","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EFDF7B07AFD6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000017/0001035267-25-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2024, filed 2025-01-31"}},"to":{"id":"clm_EFDF7B07AFD6","predicate":"revenue","value":"10,064,700,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Intuitive Surgical revenue: 10,064,700,000 United States dollar\", as of 2025-12-31. Claim clm_EFDF7B07AFD6, https://asof.is/claim/clm_EFDF7B07AFD6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm.","url":"https://asof.is/claim/clm_EFDF7B07AFD6","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2025, filed 2026-02-03"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}